MedCap is a Swedish serial acquirer and owner of specialist companies in medical technology and life science. It builds a portfolio of niche medtech and related healthcare businesses, typically with strong product or market positions in selected therapeutic or diagnostic areas. Value creation focuses on long-term ownership, operational development, and selective add-on acquisitions rather than a single product line.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 474.2 | — | 41.6 | — |
| Q1 2025 | 493.8 | — | 50.5 | — |
| Q2 2025 | 521.7 | — | 53.6 | — |
| Q4 2025 | 591 | 24.6% | 64.6 | 55.3% |
| Q1 2026 | 556.6 | 12.7% | 55.9 | 10.7% |
| Q2 2026 | 606.3 | 16.2% | 69.1 | 28.9% |
All markets — KeepWinning global stock screener
Other companies on Stockholm: Xvivo Perfusion AB (publ) (XVIVO), Dynavox Group AB (publ) (DYVOX), Synsam AB (publ) (SYNSAM), Sivers Semiconductors AB (publ) (SIVE), Apotea AB (publ) (APOTEA), Yubico AB (YUBICO)